Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. PRVA
PRVA logo

PRVA Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
23.835
Open
23.620
VWAP
23.63
Vol
1.93M
Mkt Cap
2.98B
Low
23.390
Amount
45.50M
EV/EBITDA(TTM)
43.50
Total Shares
126.01M
EV
2.62B
EV/OCF(TTM)
18.96
P/S(TTM)
1.37
Privia Health Group, Inc. is a technology-driven, national physician-enablement company. The Company collaborates with medical groups, health plans and health systems. It enhances physician practices, improves patient experiences and doctors for delivering care in both in-person and virtual care settings. Its Privia Platform is powered by the Privia Technology Solution, an end-to-end, cloud-based technology solution that integrates both Privia-developed and third-party applications into an interface and workflow that manages all aspects of its Privia Providers provision of healthcare services. Privia Platform optimizes provider workflow across the full continuum of reimbursement arrangements. The Company provides management services to each Medical Group though a local management services organization, which provides Medical Groups with access to value-based care (VBC) opportunities either directly or through Privia-owned accountable care organizations.
Show More

Events Timeline

(ET)
2026-05-27
09:10:00
Privia Health Signs Agreement with NGBC to Enter New Jersey
select
2026-05-07 (ET)
2026-05-07
06:20:00
Company Reports Q1 Revenue of $603.8M, Exceeds Consensus
select

News

Fool
5.0
06-08Fool
Privia Health CEO Sells 121,086 Shares for $2.73 Million
  • Executive Sell-off: Privia Health CEO Parth Mehrotra sold 121,086 shares between May 11 and 12, 2026, for approximately $2.73 million, reducing his direct stake by 21.80% to 434,357 shares, which may indicate a weakening confidence in the company's future prospects.
  • Transaction Context: This sale marks the largest single open-market transaction by Mehrotra on record, suggesting an acceleration in sale size likely due to a declining number of shares available for sale, indicating that future large sales may not be sustainable.
  • Market Reaction and Analysis: Despite the company reporting over 25% year-over-year revenue growth in Q1 and expanding into New Jersey, Mehrotra's sell-off could raise investor concerns about the company's outlook, especially given mixed analyst opinions on earnings risks tied to inflation.
  • Investor Considerations: The stock sale was executed under a Rule 10b5-1 trading plan, with some shares sold to cover tax withholding obligations, reminding investors that insider transactions may not necessarily reflect confidence in the stock and should be interpreted with caution.
NASDAQ.COM
5.0
06-08NASDAQ.COM
Privia Health CEO Sells 121,086 Shares for $2.73 Million
  • Executive Share Sale: Privia Health CEO Parth Mehrotra sold 121,086 shares between May 11 and 12, 2026, for approximately $2.73 million at an average price of $22.56 per share, representing a significant 21.80% reduction in his direct holdings, indicating a notable decrease in his ownership stake.
  • Transparent Trading Plan: The share sale was conducted under a Rule 10b5-1 trading plan, meaning the transactions were executed on a predetermined schedule, with some shares sold to cover tax withholding obligations, reflecting compliance and transparency in executive trading activities.
  • Strong Financial Performance: Privia Health reported over 25% year-over-year revenue growth in its Q1 2026 results, driven by same-store growth and new provider additions, demonstrating the company's success in expanding its market presence and enhancing operational efficiency.
  • Mixed Market Reactions: While J.P. Morgan raised its price target from $33 to $45 and maintained an overweight rating, Barclays cut its target from $45 to $24, indicating concerns about the company's future profitability, which has contributed to an approximately 8% decline in stock price year-to-date.
Fool
6.5
05-30Fool
Rubicon Founders Increases Stake in Privia Health Group
  • Increased Holdings: Rubicon Founders LLC increased its stake in Privia Health Group by 175,142 shares in Q1 2026, with an estimated transaction value of $3.95 million, indicating a bullish outlook as the stock now represents 88.92% of its 13F reportable AUM.
  • Financial Performance: Privia Health reported a 22% year-over-year revenue growth in 2025, reaching $2.1 billion, with net income rising 59% to $22.9 million, showcasing its strong market position and demand for its services in the healthcare sector.
  • Market Expectations: In Q1 2026, Privia Health's revenue grew 26% year-over-year to $603.8 million, with full-year revenue projected to reach around $2.4 billion, indicating that its solutions are addressing unmet needs in the healthcare industry and boding well for future success.
  • Investment Value: The increase in holdings by Rubicon Founders positions Privia Health's stock as a core asset in its portfolio, reflecting a positive long-term investment outlook that may attract further investor interest.
NASDAQ.COM
8.5
05-30NASDAQ.COM
Rubicon Founders Increases Stake in Privia Health Group
  • Increased Holdings: Rubicon Founders purchased an additional 175,142 shares of Privia Health Group in Q1 2026, with an estimated trade value of $3.95 million, indicating a strong bullish sentiment as this stock now constitutes 88.92% of the fund's reportable AUM.
  • Strong Financial Performance: Privia Health Group reported $2.1 billion in revenue for 2025, marking a 22% year-over-year increase, while net income surged 59% to $22.9 million, reflecting robust market demand and profitability in the healthcare sector.
  • Healthy Balance Sheet: As of 2025, Privia Health's total assets stood at $1.4 billion against total liabilities of $578.4 million, with no debt, showcasing a solid financial position that supports future growth initiatives.
  • Optimistic Future Outlook: In Q1 2026, Privia Health's revenue rose 26% year-over-year, with full-year projections estimating around $2.4 billion, indicating that its solutions are effectively addressing unmet needs in the healthcare industry, thus presenting significant long-term investment potential.
seekingalpha
9.5
05-07seekingalpha
Privia Health Q1 Earnings Beat Expectations with Revenue Growth
  • Earnings Highlights: Privia Health reported a Q1 non-GAAP EPS of $0.19, missing expectations by $0.06, while revenue reached $603 million, reflecting a 25.6% year-over-year increase and exceeding estimates by $41.07 million, indicating strong market performance.
  • Guidance Update for 2026: The company maintained its full-year 2026 outlook for most metrics, raising the guidance range for Attributed Lives to between 1.6 million and 1.625 million, showcasing confidence in future growth prospects.
  • Operational Efficiency Improvement: It is expected that approximately 80% of Adjusted EBITDA will convert to free cash flow in 2026, enhancing the company's financial flexibility and supporting future investments.
  • Market Expansion Plans: Privia Health targets a 19.5% growth in Adjusted EBITDA for 2026 while expanding its footprint to 24 states, further solidifying its competitive position in the national market.
moomoo
5.0
05-01moomoo
Privia Health (PRVA.US) Director Plans to Sell $40.47 Million in Common Stock via Form 144
  • Share Sale Announcement: Matthew Shawn Morris intends to sell 1.63 million shares of Privia Health (PRVA.US) on May 1, with a total market value of approximately $40.47 million.

  • Reduction in Shareholding: Since February 26, 2026, Morris has reduced his shareholding in Privia Health by 24,338 shares, valued at approximately $608.36K.

Wall Street analysts forecast PRVA stock price to rise
12 Analyst Rating
Wall Street analysts forecast PRVA stock price to rise
11 Buy
1 Hold
0 Sell
Strong Buy
Current: 0.000
sliders
Low
23.00
Averages
30.40
High
34.00
Current: 0.000
sliders
Low
23.00
Averages
30.40
High
34.00
Barclays
Andrew Mok
Equal Weight
downgrade
$25 -> $24
AI Analysis
2026-05-26
Reason
Barclays
Andrew Mok
Price Target
$25 -> $24
AI Analysis
2026-05-26
downgrade
Equal Weight
Reason
Barclays analyst Andrew Mok lowered the firm's price target on Privia Health to $24 from $25 and keeps an Equal Weight rating on the shares. The firm believes the managed care stock moves post the Q1 reports are "durable." It continues to prefer managed care over facilities, saying inflation and commercial mix represent increasing drivers of provider earnings risk. Barclays adjusted ratings and targets in the group.
Canaccord
Buy
maintain
$35 -> $34
2026-05-08
Reason
Canaccord
Price Target
$35 -> $34
2026-05-08
maintain
Buy
Reason
Canaccord lowered the firm's price target on Privia Health to $34 from $35 and keeps a Buy rating on the shares. The firm said they posted another solid quarter which portends guidance will likely moove higher considering the company's high visibility.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for PRVA
Unlock Now

Valuation Metrics

The current forward P/E ratio for Privia Health Group Inc (PRVA.O) is 26.04, compared to its 5-year average forward P/E of 48.13. For a more detailed relative valuation and DCF analysis to assess Privia Health Group Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
48.13
Current PE
26.04
Overvalued PE
337.20
Undervalued PE
-240.94

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-83.09
Current EV/EBITDA
58.38
Overvalued EV/EBITDA
958.99
Undervalued EV/EBITDA
-1125.17

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
1.80
Current PS
1.12
Overvalued PS
2.60
Undervalued PS
1.00

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

what is good stock to day trade today
Intellectia · 36 candidates
Price: $5.00 - $80.00Price Change Pct: $3.00 - $15.00Relative Vol: >= 1.50Beta: HighRiskList Exchange: XNYS, XNAS, XASEMonthly Average Dollar Volume: >= 2,000,000
Ticker
Name
Market Cap$
top bottom
BSY logo
BSY
Bentley Systems Inc
11.64B
FIGS logo
FIGS
Figs Inc
2.05B
MGNI logo
MGNI
Magnite Inc
1.95B
CRSP logo
CRSP
CRISPR Therapeutics AG
5.93B
WWW logo
WWW
Wolverine World Wide Inc
1.64B
ARHS logo
ARHS
Arhaus Inc
1.31B
what about health tech stocks and robots?
Intellectia · 18 candidates
Market Cap: 50.00M - 50.00BWeekly Average Turnover: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
ROK logo
ROK
Rockwell Automation Inc
47.26B
SYM logo
SYM
Symbotic Inc
36.98B
TER logo
TER
Teradyne Inc
36.32B
VEEV logo
VEEV
Veeva Systems Inc
36.12B
ZBRA logo
ZBRA
Zebra Technologies Corp
12.31B
DOCS logo
DOCS
Doximity Inc
7.50B

Whales Holding PRVA

O
OneDigital Investment Advisors, LLC
Holding
PRVA
+12.33%
3M Return
D
Durable Capital Partners, LP
Holding
PRVA
+5.69%
3M Return
R
Riverbridge Partners, LLC
Holding
PRVA
+3.04%
3M Return
V
Van Berkom and Associates Inc.
Holding
PRVA
+0.63%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Privia Health Group Inc (PRVA) stock price today?

The current price of PRVA is 23.67 USD — it has increased 1.11

What is Privia Health Group Inc (PRVA)'s business?

Privia Health Group, Inc. is a technology-driven, national physician-enablement company. The Company collaborates with medical groups, health plans and health systems. It enhances physician practices, improves patient experiences and doctors for delivering care in both in-person and virtual care settings. Its Privia Platform is powered by the Privia Technology Solution, an end-to-end, cloud-based technology solution that integrates both Privia-developed and third-party applications into an interface and workflow that manages all aspects of its Privia Providers provision of healthcare services. Privia Platform optimizes provider workflow across the full continuum of reimbursement arrangements. The Company provides management services to each Medical Group though a local management services organization, which provides Medical Groups with access to value-based care (VBC) opportunities either directly or through Privia-owned accountable care organizations.

What is the price predicton of PRVA Stock?

Wall Street analysts forecast PRVA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PRVA is30.40 USD with a low forecast of 23.00 USD and a high forecast of 34.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Privia Health Group Inc (PRVA)'s revenue for the last quarter?

Privia Health Group Inc revenue for the last quarter amounts to 603.85M USD, increased 25.78

What is Privia Health Group Inc (PRVA)'s earnings per share (EPS) for the last quarter?

Privia Health Group Inc. EPS for the last quarter amounts to 0.02 USD, decreased -33.33

How many employees does Privia Health Group Inc (PRVA). have?

Privia Health Group Inc (PRVA) has 1226 emplpoyees as of June 20 2026.

What is Privia Health Group Inc (PRVA) market cap?

Today PRVA has the market capitalization of 2.98B USD.